SCHEMBL971763

SCHEMBL971763

[CH2]C#CCC[CH2]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8991789 0.81
SCHEMBL3923587 0.79
SCHEMBL5985549 0.79
SCHEMBL3924832 0.79
SCHEMBL5986206 0.76
SCHEMBL3928014 0.76
SCHEMBL5855746 0.74 RAB9A (0.31)
SCHEMBL5985239 0.74 RAB9A (0.31)
SCHEMBL5983964 0.74 RAB9A (0.31)
SCHEMBL5984438 0.74 RAB9A (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 297 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009005839-A2 COMPOUNDS AND METHODS OF USE THE GOVERNMENT OF THE U.S.A. AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH & HUMAN SERVICE (US) 2009-01-08 WO claimed
WO-2024149093-A1 GLUCOCORTICOID RECEPTOR AGONIST AND CONJUGATE THEREOF 四川科伦博泰生物医药股份有限公司 2024-07-18 WO disclosed
CN-118165031-A Nitrile compound, electrolyte, secondary battery and device 蔚来电池科技(安徽)有限公司 2024-06-11 CN disclosed
WO-2024114523-A1 ANTIBODY-DRUG CONJUGATE, PREPARATION METHOD THEREFOR, AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2024-06-06 WO disclosed
WO-2024114318-A1 DRUG LINKER COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2024-06-06 WO disclosed
WO-2024114531-A1 HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2024-06-06 WO disclosed
CN-118105508-A Medicinal linker compound, preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2024-05-31 CN disclosed
CN-118073655-A Electrolyte, secondary battery and device 蔚来电池科技(安徽)有限公司 2024-05-24 CN disclosed
CN-118026988-A Ethylene carbonate compound, electrolyte, secondary battery and device 蔚来电池科技(安徽)有限公司 2024-05-14 CN disclosed
WO-2024078586-A1 ANTIBODY-DRUG CONJUGATE BINDING TO HUMAN PTK7 AND METHOD FOR PREPARATION AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2024-04-18 WO disclosed
US-4997848-A Enzyme inhibitors SANKYO COMPANY, LIMITED (JP) 1991-03-05 US disclosed
US-4992455-A Cardiovascular disorders SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1991-02-12 US disclosed
EP-0383256-A2 A novel substituted-acetamide compound and a process for the preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-08-22 EP disclosed
EP-0314435-A2 Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition, processes for their preparation and compositions containing them Sankyo Company Limited (JP) 1989-05-03 EP disclosed
US-4795814-A CORONARY VASODILATORS, HYPOTENSIVE AGENTS, ANTIINFLAMMATORY AGENTS, ANTITUMOR AGENTTS, ENZYME INHIBITORS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-01-03 US disclosed
EP-0292305-A1 Novel thiazolidin-4-one derivatives and acid addition salts thereof SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1988-11-23 EP disclosed
US-4782160-A CALCIUM RECEPTOR ANTAGONISTS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1988-11-01 US disclosed
EP-0276552-A1 1,4-dihydropyridine derivatives and their production YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1988-08-03 EP disclosed
EP-0173126-A1 Process for preparing novel dihydropyridine derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-03-05 EP disclosed
EP-0145434-A2 Novel dihydropyridine derivatives and process for preparing the same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1985-06-19 EP disclosed